CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
-2.45%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.72B
AUM Growth
+$1.72B
Cap. Flow
-$240M
Cap. Flow %
-13.93%
Top 10 Hldgs %
58.91%
Holding
67
New
8
Increased
11
Reduced
11
Closed
17

Top Buys

1
RAPP
Rapport Therapeutics
RAPP
$68.4M
2
AXSM icon
Axsome Therapeutics
AXSM
$32.2M
3
PCVX icon
Vaxcyte
PCVX
$31.3M
4
ALMS
Alumis Inc. Common Stock
ALMS
$28.6M
5
URGN icon
UroGen Pharma
URGN
$27.7M

Top Sells

1
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$107M
2
TARS icon
Tarsus Pharmaceuticals
TARS
$44.6M
3
AUTL
Autolus Therapeutics
AUTL
$42.2M
4
ALXO icon
ALX Oncology
ALXO
$35M
5
BBIO icon
BridgeBio Pharma
BBIO
$34.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VTYX icon
51
Ventyx Biosciences
VTYX
$184M
– –
-2,710,000
Closed -$14.9M
TRML icon
52
Tourmaline Bio
TRML
$645M
– –
-1,250,000
Closed -$28.6M
SYRE icon
53
Spyre Therapeutics
SYRE
$1.02B
– –
-250,000
Closed -$9.48M
SIGA icon
54
SIGA Technologies
SIGA
$617M
– –
0
– –
RCKT icon
55
Rocket Pharmaceuticals
RCKT
$358M
– –
-300,000
Closed -$8.08M
NKTX icon
56
Nkarta
NKTX
$149M
– –
-1,350,000
Closed -$14.6M
IRON icon
57
Disc Medicine
IRON
$2.14B
– –
-125,000
Closed -$7.78M
IMRX icon
58
Immuneering
IMRX
$229M
– –
-3,295,273
Closed -$9.52M
IBRX icon
59
ImmunityBio
IBRX
$2.24B
– –
0
– –
CABA icon
60
Cabaletta Bio
CABA
$144M
– –
-1,100,000
Closed -$18.8M
BEAM icon
61
Beam Therapeutics
BEAM
$1.9B
– –
0
– –
BCAB icon
62
BioAtla
BCAB
$28.7M
– –
-1,170,870
Closed -$4.03M
JBIO
63
Jade Biosciences, Inc. Common Stock
JBIO
$245M
– –
-1,069,796
Closed -$31.6M
AUTL
64
Autolus Therapeutics
AUTL
$383M
– –
-6,616,667
Closed -$42.2M
ATXS icon
65
Astria Therapeutics
ATXS
$394M
– –
-1,300,000
Closed -$18.3M
APLS icon
66
Apellis Pharmaceuticals
APLS
$3.51B
– –
-400,000
Closed -$23.5M
ALXO icon
67
ALX Oncology
ALXO
$54.6M
– –
-3,142,079
Closed -$35M
1 2
3